About 500mg Hepcvel Sofosbuvir Velpatasvir Tablets
| Dose/Strength |
500mg |
| Packaging Type |
Bottle |
| Brand Name |
Hepcvel |
| Packaging Size |
28 tablets in 1 bottle |
| Manufactured By |
Cipla |
| Composition |
Sofosbuvir + Velpatasvir |
| Usage/Application |
hepatitis C virus (HCV) infection. |
Hepcvel Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.
Hepcvel Tablet should be taken in the prescribed dose and duration. It can be taken with or without food, but take it at the same time daily. It is advised not to consume more than the recommended dose. It is important to inform your doctor if you have any health conditions such as liver or kidney disease. It is harmful to consume alcohol along with this medicine, so it is advised to limit or avoid alcohol. The course of the medicine should be completed for better results.
The common side effects of this medicine are tiredness and headache. You should drink plenty of fluid and eat a healthy diet to prevent or overcome the side effects. Before taking the medicine, inform your doctor if you are taking any other medicines or supplements.
Comprehensive Antiviral Therapy for HCVHepcvel tablets offer an effective, all-in-one oral regimen for adults diagnosed with chronic hepatitis C, covering all major genotypes. Composed of Sofosbuvir and Velpatasvir, this combination inhibits crucial viral enzymes, helping to clear the infection and reduce the risk of liver complications. The consistent once-daily dosage and broad-spectrum efficacy make Hepcvel a preferred choice for simplifying HCV treatment.
Safe and Convenient AdministrationPrescribed exclusively for adults, Hepcvel is taken orally, with or without food. Designed for ease of use, its 28-tablet packaging supports a full monthly treatment cycle. Patients are advised to strictly follow medical guidance and not self-medicate. To maintain the medication's potency, store it in a dry environment below 30C, and protect it from direct sunlight.
FAQ's of 500mg Hepcvel Sofosbuvir Velpatasvir Tablets:
Q: How should Hepcvel Tablets be taken for chronic hepatitis C infection?
A: Hepcvel should be taken orally once daily, as directed by your physician. The tablet can be taken with or without food at the same time each day. Do not alter the prescribed dosage or discontinue treatment without consulting your healthcare provider.
Q: What are the main benefits of using Hepcvel Sofosbuvir Velpatasvir Tablets?
A: Hepcvel provides an effective, single-tablet solution that targets all major genotypes (1-6) of chronic hepatitis C virus. This simplifies treatment regimens for adults and increases the likelihood of viral clearance, potentially reducing future liver-related complications.
Q: Who should not use Hepcvel Tablets?
A: Hepcvel is not recommended for pediatric patients, pregnant or breastfeeding women unless specifically prescribed. Individuals with hypersensitivity to any ingredients, or those with severe renal or hepatic impairment, should avoid this medication. Always discuss your medical history with your doctor before starting treatment.
Q: What side effects might occur during Hepcvel therapy?
A: Common side effects include headache, fatigue, nausea, and anemia. If you experience severe or persistent side effects, consult your physician immediately. Your doctor will help manage any adverse effects to ensure safe and effective therapy.
Q: How should Hepcvel Tablets be stored to maintain their effectiveness?
A: Store Hepcvel tablets below 30C in a dry location, protected from light and moisture. Keep the medication in its original packaging and out of reach of children. Never use tablets beyond their stated expiration date on the packaging.
Q: When is Hepcvel treatment typically recommended?
A: Hepcvel is prescribed for adults with chronic hepatitis C virus infection, regardless of genotype, when a physician determines that a combination therapy is appropriate. Always follow your healthcare provider's recommendations regarding timing and duration of therapy.